Methyl Alcohol

Methyl Alcohol

SCHEMBL5605876

CCCCOC(=O)C=O.CO

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.68
TSHR P16473 5/20 0.63
HPGD P15428 1/20 0.63
HCAR2 Q8TDS4 4/20 0.59
ALDH1A1 P00352 2/20 0.54
MAPT P10636 1/20 0.50
RAB9A P51151 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
NAAA Q02083 1/20 0.43
APP P05067 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP3A4 P08684 1/20 0.41
EPHX1 P07099 1/20 0.41
LMNA P02545 1/20 0.40
ESR1 P03372 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL195396 0.98
SCHEMBL8992513 0.95 ATM (0.68) ATMTSHRHPGDHCAR2ALDH1A1
Water SCHEMBL7567022 0.95 ATM (0.68) ATMTSHRHPGDHCAR2ALDH1A1
Alcohol SCHEMBL27686238 0.93 ATM (0.65) ATMTSHRHPGDHCAR2ALDH1A1
SCHEMBL525121 0.91 HCAR2 (0.62) ATMTSHRHPGDHCAR2ALDH1A1
Butyl Alcohol SCHEMBL27705263 0.90 ATM (0.61) ATMTSHRHPGDHCAR2ALDH1A1
SCHEMBL6679650 0.89 HCAR2 (0.63) ATMTSHRHPGDHCAR2ALDH1A1
SCHEMBL6676413 0.89 HCAR2 (0.63) ATMTSHRHPGDHCAR2ALDH1A1
SCHEMBL6680945 0.89 HCAR2 (0.63) ATMTSHRHPGDHCAR2ALDH1A1
SCHEMBL6675004 0.89 HCAR2 (0.63) ATMTSHRHPGDHCAR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101454270-A Process for preparing hydroxy-aromatic resins, hydroxy-aromatic resins and modifications thereof DSM IP ASSETS BV (NL) 2009-06-10 CN claimed
CN-101977983-A Composition comprising a blend of resins DSM IP ASSETS BV 2011-02-16 CN disclosed
CN-101977951-A Composition comprising a polyol DSM IP ASSETS BV 2011-02-16 CN disclosed
CN-101454270-A Process for preparing hydroxy-aromatic resins, hydroxy-aromatic resins and modifications thereof DSM IP ASSETS BV (NL) 2009-06-10 CN disclosed
CN-101068841-A Hydroxy-aromatic compound, process for the preparation thereof, and use of the compound DSM IP ASSETS BV (NL) 2007-11-07 CN disclosed
US-7169950-B2 Method for producing monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) 2007-01-30 US disclosed
US-20040073041-A1 Method for producing monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG (AT) 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073041-A1 Method for producing monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds OXER1, FHIT, HAO2 ATM 3649/4885TSHR 4737/4885HPGD 793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.